Sephy Philip

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Acute Heart Failure

Cardiovascular Disease

Placebo Controlled

Top Venues

Journal of the American Heart Association

Annals of medicine and surgery (2012)

Future cardiology

Vascular health and risk management

This page only lists publications with an associated author ORCID identifier.

Publications

William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
Sephy Philip
Re: 'Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: a meta-analysis'. Annals of medicine and surgery (2012) 85 (2) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
Sephy Philip
Re: 'Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: a meta-analysis'. Annals of medicine and surgery (2012) 85 (2) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
Peter P Toth, Michael Hull, Craig Granowitz, Sephy Philip
Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database. Future cardiology 17 (4) (2020)
Peter P Toth, Sephy Philip, Michael Hull, Craig Granowitz
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients. Vascular health and risk management 15 (2019)